We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Autologous hematopoietic transplantation following COVID‐19 infection.
- Authors
Brzycki, Marthilde; Richard, Robert; Burwick, Nicholas; Graf, Solomon; O'Brien, Craig; Wu, Daniel; Chauncey, Thomas R.
- Abstract
Autologous hematopoietic cell transplantation following induction therapy is standard of care for most patients with newly diagnosed multiple myeloma (N Engl J Med 2017, 376; 1311). Though active COVID‐19 infection is typically a contraindication to aggressive therapy, little is known about the safety of autologous transplantation after resolution of acute symptoms and undetectable pathogen by nasopharyngeal PCR.
- Subjects
COVID-19; AUTOTRANSPLANTATION; HEMATOPOIETIC stem cell transplantation; MULTIPLE myeloma; SYMPTOMS
- Publication
Clinical Case Reports, 2021, Vol 9, Issue 3, p1167
- ISSN
2050-0904
- Publication type
Article
- DOI
10.1002/ccr3.3712